#VisualAbstract: Trastuzumab does not improve survival in patients with esophageal adenocarcinoma with HER2 overexpression Apr 28, 2022 Click to read this study in The Lancet Oncology. Author admin View all posts
Create Post
Twitter/X Preview
Logout